Six ReWalk Exoskeleton Systems Shipped for Initial Phase of Four-Year VA Study

Med Device Online reported that the exoskeletons will be used in a Multi-Center Study by the Veterans Administration (VA), which is the largest single healthcare provider to persons with Spinal Cord Injury (SCI) in the United States.

You can find the full details of the study that the VA released under the title "Exoskeleton Assisted-Walking in Persons With SCI: Impact on Quality of Life" in the clinical trials section of the National Institutes of Health (NIH) website with the Identifier: NCT02658656.

The Med Device Online article quoted ReWalk CEO Larry Jasinski as saying "This VA clinical trial is groundbreaking in both its purpose and scope, and will undoubtedly provide a wealth of quality research data to the department's already impressive research."